Henry Ford Health

Henry Ford Health Scholarly Commons
Center for Health Policy and Health Services
Research Articles

Center for Health Policy and Health Services
Research

5-1-2022

Suicide Deaths Before and During the Coronavirus Disease 2019
Pandemic: An Interrupted Time-series Study
Rebecca C. Rossom
Robert B. Penfold
Ashli A. Owen-Smith
Greg E. Simon
Brian K. Ahmedani

Follow this and additional works at: https://scholarlycommons.henryford.com/chphsr_articles

ORIGINAL ARTICLE

Suicide Deaths Before and During the Coronavirus
Disease 2019 Pandemic
An Interrupted Time-series Study
Rebecca C. Rossom, MD, MS,* Robert B. Penfold, PhD,† Ashli A. Owen-Smith, PhD,‡
Greg E. Simon, MD, MPH,† and Brian K. Ahmedani, PhD§

Introduction: With stressors that are often associated with suicide
increasing during the coronavirus disease 2019 (COVID-19) pandemic, there has been concern that suicide mortality rates may also
be increasing. Our objective was to determine whether suicide
mortality rates increased during the COVID-19 pandemic.
Methods: We conducted an interrupted time-series study using data from
January 2019 through December 2020 from 2 large integrated health care
systems. The population at risk included all patients or individuals enrolled
in a health plan at HealthPartners in Minnesota or Henry Ford Health
System in Michigan. The primary outcome was change in suicide mortality rates, expressed as annualized crude rates of suicide death per
100,000 people in 10 months following the start of the pandemic in March
2020 compared with the 14 months prior.
Results: There were 6,434,675 people at risk in the sample, with
55% women and a diverse sample across ages, race/ethnicity, and
insurance type. From January 2019 through February 2020, there
was a slow increase in the suicide mortality rate, with rates then
decreasing by 0.45 per 100,000 people per month from March 2020
through December 2020 (SE = 0.19, P = 0.03).
Conclusions: Overall suicide mortality rates did not increase with
the pandemic, and in fact slightly declined from March to December
2020. Our ﬁndings should be conﬁrmed across other settings and,
when available, using ﬁnal adjudicated state mortality data.
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G

iven increases in risk factors for suicide with the onset of
the coronavirus disease 2019 (COVID-19) pandemic,
including increases in social isolation, economic privation,
bereavement, domestic violence, ﬁrearm and alcohol purchases, and prevalence of depression and anxiety, as well as
reduced access to health care and services that support families experiencing or at risk for violence, there have been
concerns that suicide rates would increase during the
pandemic.1–3 Suicide attempt data are often more timely than
suicide death data, but suicide attempts may be greatly underreported during periods when health care access and utilization decrease, which they did during the pandemic.
Suicide death data are recorded by state medical examiners
and are not underreported when health care utilization declines, but lags in ﬁnal reporting of state mortality data can
make timely assessment of trends in suicide mortality challenge.
To address the gap in understanding of the effects of the
pandemic on suicide deaths, this interrupted time-series study
utilized interim mortality data from patients in Michigan and
Minnesota to examine changes in suicide mortality rates before and after March 2020, when the World Health Organization ofﬁcially declared a pandemic and many changes in
employment, school and public health policy related to the
pandemic were ﬁrst implemented in the United States.4

METHODS
The population at risk in this sample included all patients and insurance members of HealthPartners in Minneapolis and Henry Ford Health System in Detroit, and study
activities were reviewed and approved by Institutional Review Boards at each site. Neighborhoods were deﬁned using
census block data. Income and education were estimated
using publicly available Federal Information Processing
System (FIPS) values set by the National Institute of Standards & Technology.5
We measured suicide deaths and not suicide attempts
because changes in suicide attempts are likely confounded by
changes in care-seeking that present fewer opportunities for
documentation of the occurrence of suicide attempts. Decreases in care-seeking have been similarly observed for other
life-threatening disorders that had previously been considered
to be obligatory conditions for emergent care, including
myocardial infarction or stroke.6 In contrast, suicide death
www.lww-medicalcare.com
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rates are collected and reported by state medical examiners,
and the assessment of suicide deaths is not inﬂuenced by
likelihood to seek care during the pandemic. We chose a
static denominator based on enrollment and utilization in
January 2019 to avoid inﬂating the suicide mortality rate as an
artifact of disenrollment related to job loss or lack of careseeking; that is, allowing reductions in the denominator
would have likely inﬂated suicide death rates. Monthly state
reported of preliminary cause of death were obtained from
state vital statistics records and stored in each health care
system’s virtual data warehouse. Deaths were considered to
be suicide deaths if they were categorized as such by the state.
Preliminary cause of death was used because the adjudicated
state mortality data are not typically available until
9–12 months after the end of the previous calendar year. Each
state’s preliminary cause of death data were obtained
monthly, with a lag of 1–2 months; data for calendar years
2019 and 2020 were harvested in March 2021. Deaths were
available for all people included in our denominators regardless of whether they were still enrolled in the health plan
at the time of their death.
We employed an interrupted time-series design7 and used
segmented regression8 to evaluate the change in annualized
crude rates of suicide death per 100,000 people in 14 months
before March 2020 (when COVID-19 was declared a pandemic
by the World Health Organization4) and ﬁrst 10 months of the
pandemic. Consistent with standard speciﬁcations,8 the model
included a term indexing the secular trend in time, a term for
immediate change in level (intercept), and a term for the change
in slope. We evaluated the presence of autocorrelation via the
Durbin-Watson statistic at lags up to 12 months. All analyses
were performed in SAS 9.4.9
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TABLE 1. Demographic Characteristics of the Total Population
at Risk for Each Health Care System as of January 2019
Total Population
at Risk
Age (y)
0–19
20–39
40–64
65+
Sex: women
Insurance
Insurance commercial
Insurance Medicaid
Insurance Medicare
Insurance self-pay
Insurance other
Lower neighborhood
income (< $25,000)
Lower neighborhood
education (< 25% of
residents with at least
some college)
Race/ethnicity
Asian
Black
Hawaiian/Paciﬁc
Islander
Native American/
Alaskan Native
White
Multiple/other
Unknown
Hispanic

HealthPartners
(N = 3,431,542) (%)

Henry Ford Health
System
(N = 3,003,133) (%)

27.1
28.0
36.3
8.6
52.2

17.2
20.9
36.7
25.3
57.0

70.3
16.4
5.3
1.7
6.3
1.3

42.2
19.9
20.5
16.6
0.8
6.8

34.2

51.9

3.9
6.1
0.2

2.6
22.9
0.1

0.6

0.4

48.0
0.5
38.3
2.4

60.1
3.9
10.0
3.4

DISCUSSION

Demographic characteristics of the 6,434,675 people at
risk are summarized in Table 1 and were generally consistent
with US population as a whole,10 with our sample having
slightly more women and slightly fewer people who selfidentify as Asian, Hawaiian/Paciﬁc Islander, or Native
American/Alaskan Native than the US general population.
Overall, 54% of patients in our sample were women, and 22%
were ages 0–19, 25% ages 20–39, 36% ages 40–64, and 16%
over the age of 65. Fifty-seven percent of people were insured
by commercial insurance, 18% by Medicaid, and 13% by
Medicare. Forty-two percent of people lived in neighborhoods where <25% of residents had at least some college
education. Three percent of patients were Asian, 14% Black,
54% White, and 2% Hispanic.
From January 2019 through February 2020, overall
suicide mortality rates slowly increased to 14.6 per 100,000.
These rates were generally consistent with national data reporting a 2019 suicide death rate of 13.9 per 100,000.11
Suicide mortality rates then slowly decreased from 13.4 in
March 2020 to 10.8 in December 2020 (a decrease of 0.45 per
100,000 people per month, SE = 0.19, P = 0.03; Fig. 1). The
Durbin-Watson statistic was 2.49 (Pr <DW = 0.723); no lag
between 1 and 12 months was statistically signiﬁcant, so no
autoregressive parameters were included in the model.

Despite increases in many risk factors for suicide with
the onset of the COVID-19 pandemic, as well as evidence
that COVID-19 infection itself can increase psychiatric illness
and suicidal ideation,12 suicide mortality rates in our sample
did not increase in the ﬁrst 10 months of the pandemic, and in
fact, slightly declined.
Studies examining suicide rates during the current
COVID-19 pandemic are starting to emerge, with most similarly ﬁnding declining suicide death rates during the pandemic. One study examining leading causes of death in the
United States found that suicide deaths declined by 5.6%
from 2019 to 2020.13 Another study found that total ageadjusted suicide mortality rates decreased by 20% during the
lockdown (March 10, 2020–May 20, 2020) in Connecticut
compared with the previous year.14 However, in contrast to
most studies reporting decreased suicide rates for general
populations during the pandemic, suicide rates for non-white
patients in Connecticut increased by 62% during the lockdown compared with the previous year. A third study found
that the suicide death rate in Massachusetts a nonsigniﬁcant
decline from 0.80 per 100,000 person-months during March
to May 2019 to 0.67 per 100,000 person-months from March
to May 2020 (incident rate ratio, 0.84; 95% conﬁdence interval, 0.64–1.00).15 Finally, in contrast, a study using national observational data from Japan found that suicide
mortality rates increased for the months of July through
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Suicide Deaths and COVID

Annualized Suicide Deaths per 100,000 in Two Mid-Western Health Systems: 2019-2020
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FIGURE 1. Annualized suicide deaths per 100,000 in 2 Midwestern Health Systems: 2019–2020.

November 2020 for women and in October and November
2020 for men when compared with 2016–2019 data.16 As
additional suicide mortality data become available in the
United States, this may help clarify some of the complex
relationships between the increased stress and mental health
burden many are experiencing during the pandemic and the
decreased rates of suicide mortality we found in this study. It
will be particularly important to examine suicide rates among
potentially vulnerable populations, such as women, people of
racial and ethnic minority groups, and elderly people.
Our ﬁndings were likely inﬂuenced by the context and
experience of the COVID-19 pandemic in Michigan and
Minnesota, the states in which are samples are based. In
Michigan, COVID-19 case rates were relatively ﬂat until an
abrupt rise in cases in November 2020 through January
2021.17 COVID-19 deaths in Michigan spiked in April
through May 2020 and again in December 2020 through
February 2021. In Minnesota, COVID-19 case rates rose
slowly from April 2020 until a fairly abrupt peak in COVID19 cases and deaths in November and December of 2020.18
An indoor mask mandate was in place from April 26, 2020, to
June 22, 2021 (423 d) in Michigan and from July 25, 2020,
through May 14, 2021, in Minnesota (294 d); the duration of
these mask mandates was a little higher than the norm, as
state mask mandates ranged from 56 days to over 600 days
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

(ongoing as of December 2021) during the pandemic.19 Associations between suicide death and the pandemic may have
been different in other states with different experiences of the
COVID-19 pandemic.
Our ﬁndings are consistent with those reported for
previous national emergencies, such as the terrorist attacks of
September 11, 2001, or the 1995 Oklahoma City bombing,
when there were no measurable changes in suicide rates for
local communities or states directly affected by these traumas,
nor were national suicide rates affected.20,21 However, our
ﬁndings are in contrast with those associated with previous
viral epidemics and quarantines, as suicide deaths increased
in the United States during the 1918–1919 ﬂu pandemic and
among older adults in Hong Kong during the 2003 severe
acute respiratory syndrome epidemic.22–24 The reasons for
this juxtaposition between increased factors often associated
with suicide occurring during the pandemic and a lack of
increased suicide mortality rates in our study are not yet well
understood. Suicide mortality rates should continue to be
monitored moving forward in the context of an ongoing
pandemic and the continuation of risk factors, such as extended social isolation, that may exacerbate suicide risk.
Our study has several potential limitations that should
be taken into careful consideration. First, our study uses
monthly state reports of preliminary cause of death rather than
www.lww-medicalcare.com
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the ﬁnal adjudicated cause of death data; future studies should
use fully adjudicated state mortality data when these are
available. Second, despite having a large sample of over 6
million people, our sample was not large enough to examine
changes in suicide mortality by age or race, and ethnicity.
Third, data in this study are from patients receiving care in
integrated health care systems in the Midwest, and therefore
our study results may not generalize to other groups.

CONCLUSIONS

Suicide death rates did not increase during the ﬁrst
10 months of the pandemic at 2 large integrated health care
systems, and in fact, suicide mortality rates slightly declined.
These ﬁndings should be conﬁrmed across other care settings
and regions, and should make use of ﬁnal adjudicated state
mortality data when available.
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